AI vs. standard reading for suspected Crohn disease
Part of Digestive system clinical trials.
This study tests whether an artificial intelligence (AI) system can help doctors find signs of Crohn's disease better than standard reading of capsule endoscopy images. It is for people who have symptoms that might be Crohn's but whose colonoscopy didn't clearly show the problem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You have symptoms that could be Crohn's disease, and a recent colonoscopy either came back normal or showed only mild, nonspecific signs of inflammation (not a clear diagnosis).
- You must not already have a known diagnosis of Crohn's disease.
- You must not have other active bowel conditions like diverticulitis, colorectal cancer, ulcerative colitis, infectious colitis, or microscopic colitis.
- You must not have a blocked bowel or stomach emptying problems, and you must not have used NSAID pain relievers (like ibuprofen or naproxen) within the last month.
- You cannot be pregnant or have severe kidney disease, and you must be able to swallow a capsule (a small camera pill).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses AI to improve MRI scans for detecting intestinal fibrosis (scarring) in people with Crohn's disease who are scheduled for surgery. It aims to help doctors better identify and treat scarring.
This trial tests an AI system to help detect and describe chronic diseases of the small intestine. If you are an adult having a small bowel endoscopy or capsule endoscopy, you may be able to join.
This study uses artificial intelligence to help doctors predict if colon polyps are harmless during a colonoscopy. This could reduce the need for lab tests and save costs.
This trial uses artificial intelligence during colonoscopy to predict if Crohn's disease will come back after surgery. It aims to improve early detection and guide treatment decisions.
This study compares how accurately a new AI tool reads capsule endoscopy videos (a small camera you swallow to look inside your digestive tract) versus standard reading methods. No new procedures will be done—researchers will only re-examine videos already taken.
This pilot study uses a special AI-powered camera and a safe fluorescent dye during your scheduled colonoscopy to map how much fluid leaks through your gut lining. The goal is to better understand gut barrier damage in inflammatory bowel disease and help doctors assess disease severity.
Hear when a new Crohn Disease (CD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.